Dr. Cackowski earned his M.D. and Ph.D. degrees from the University of Pittsburgh and then completed his Internal Medicine Residency and subsequently, his Hematology/Oncology Fellowship at the University of Michigan in 2017.
While at the University of Michigan as a fellow and later as a Clinical Lecturer, he developed particular expertise in the treatment of patients with genitourinary cancers. He also developed a laboratory research program studying prostate cancer dormancy and recurrence — how patients with prostate cancer can relapse months, years, or decades after curative-intent surgery or radiation. His research laboratory is funded by grants from the Prostate Cancer Foundation and the Department of Defense.
Dr. Cackowski joined the medical staff at Karmanos Cancer Center and Wayne State University in May 2020 where he continues to treat patients with genitourinary cancers, leads a laboratory investigating ways in which prostate cancer recurs and resists treatment and conducts clinical trials of genitourinary cancers.
The Barbara Ann Karmanos Cancer Institute’s fourth annual Prostate Cancer Awareness Night with the Detroit Tigers and McLaren Health Care, the official health care system of the Tigers, was a home run on Monday, July 8. Hundreds of prostate cancer survivors and their loved ones were brought together under the lights of Comerica Park as the Detroit Tigers beat their division rival, the Cleveland Guardians. This awareness game also provided crucial information on early detection, highlighted the importanc...
Frank Cackowski, M.D., Ph.D. , medical oncologist and member of the Genitourinary Oncology Multidisciplinary Team at the Barbara Ann Karmanos Cancer Institute, was named on the inaugural America’s Best Prostate Cancer Oncologists lists. The list is published by Newsweek, who partnered with Statista to rank the specialists. The ranking lists the top 150 oncologists and urologists across the country who specialize in prostate cancer care. When ranking, Newsweek and Statista looked at data from four source...
Elisabeth Heath, M.D., FACP , leader of the Genitourinary Oncology Multidisciplinary Team (MDT) and member of the Phase 1 Clinical Trials MDT at the Barbara Ann Karmanos Cancer Institute, has received grant renewal from the U.S. Department of Defense to continue membership in the prestigious Prostate Cancer Clinical Trials Consortium (PCCTC) program. The Prostate Cancer Clinical Consortium Award is a peer-reviewed, competitive grant. Peers include scientific researchers at universities and cancer center...